DGSA is named in his honour, and has offered courses in dry needling and manual trigger point therapy worldwide since 1995 (although they seem to be primarily serving Europe). David G. Simons Academy (DSGA) PRO PATIENT — Dr. Simons co-authored the famous big red texts — the seminal text on myofascial pain syndrome — with Dr. Janet Travell. Neil Asher Continuing Education for Manual Therapists PRO — "Neil Asher Technique" is branded approach to trigger point therapy, and the website is mostly built around a directory of NAT certified therapists. The MTF website has a strong focus on research and they publish the International Journal of Therapeutic Massage & Bodywork, which routinely publishes papers about myofascial pain syndrome. Massage Therapy Foundation (MTF) PRO — A nonprofit organization to advance the profession of massage therapy, founded by the American Massage Therapy Association.
Myofascial therapy can also enhance or assist other treatments to increase their effectiveness such as acupuncture, manipulation, physical therapy, or occupational therapy. Myofascial therapy can be a precursor and complement to other treatments. The goal of myofascial therapy is to stretch and loosen the fascia so that it and other contiguous structures can move more freely, and the patient's motion is restored.
You’ll use a foam roller or roller massager to gently apply pressure to your fascial tissues. You can find videos online with basic myofascial release techniques. You can perform myofascial release on yourself at home. Myofascial release therapy, like other methods of massage therapy, doesn’t have many risks. Myofascial release therapy may help anyone who has tightness in their fascial tissues.
Other experimental models have evaluated an increase in pain thresholds following the administration of testosterone, noticing less responsiveness to nociceptive stimuli after the hormone administration 23,32. The opposite was also true in male rats undergoing estrogen therapy, showing an increased pain sensitivity . It was observed that female rats responded to less intense painful stimuli in comparison with male rats. In an experimental model, rats from both sexes were exposed to mechanical colorectal distention and pain perception was measured. Ovariectomized female rats experienced 50% reduction in pain perception upon beginning hormone replacement with 17β-estradiol.
Following either testosterone or placebo pellet implantation, all animals were moved to single cage housing to protect the surgical sites. In orchiectomized male mice, the pellets were inserted at the same time as the orchiectomy surgery. Time release testosterone pellets (7.5 mg testosterone/pellet, 60-day release; Innovative Research of America, Sarasota, FL) or placebo pellets were inserted subcutaneously. Activation of androgen receptors transcriptionally increases expression of mu-opioid and cannabinoid type 1 receptors on peripheral nociceptors both of which have anti-nociceptive effects 3;34;35;47;70. In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy.
Administration of testosterone to females or orchiectomized males produced unilateral, shorter lasting hyperalgesia. In addition, pain can also be generated from damaged myofascial tissue itself, sometimes at a 'trigger point' where a contraction of muscle fibers has occurred. Many patients seek myofascial treatment after losing flexibility or function following an injury or if experiencing ongoing back, shoulder, hip, or virtually pain in any area containing soft tissue. On the other hand, estrogen fluctuations provide an explanation for the lower pain threshold seen in females.

Gender: Female

Social links